Volume 21, Issue 3 (11-2019)                   yafte 2019, 21(3): 1-11 | Back to browse issues page

XML Persian Abstract Print


,Sport Sciences Department, Shiraz University, Shiraz, Iran
Abstract:   (4310 Views)
Background: Breast cancer and its treatments induce various physical complications, including cardiovascular problems. Exercise training is one of the recommended methods for preventing or reducing these complications. The purpose of this research was to evaluate the impact of 8 weeks of Pilates exercises on cardiovascular indices in breast cancer patients.
Materials and Methods: This study was a randomized clinical trial. Participants of the study included 30 female breast cancer patients who participated in the study voluntarily. They were randomly divided into two groups of the exercise (n=15) and the control (n=15). The exercise group performed Pilates exercise for 8 weeks, 3 days a week, for 60 min per session, but the control group did not participate in any regular physical activity. The resting heart rate and systolic as well as diastolic blood pressure were measure using a blood pressure monitor device prior to and after the training period of the both groups. Subsequently, the rate pressure product and the resting systolic heart rate were separately multiplied by resting heart rate. Analysis of covariance statistical test was used to carry out data analysis.
Results: Pilates exercises decreased systolic blood pressure (P<0.035), heart rate (P<0.02) and rate pressure product (P<0.003) in breast cancer women, but did not have any effect on their diastolic blood pressure (P<0.18).
Conclusion: Women with breast cancer are recommended to perform Pilates exercises for the improvement of their cardiovascular indices.
 
Full-Text [PDF 300 kb]   (1096 Downloads)    
Type of Study: Applicable | Subject: فیزیولوژی انسانی
Received: 2019/03/19 | Accepted: 2019/11/16 | Published: 2019/12/3

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.